Abel Hall LLC’s Niagen Bioscience NAGE Stock Holding History

Abel Hall LLC’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$99.4K	Buy	+34,038	New	+$109K	0.02%	780

Other funds holding NAGE

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return

Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Abel Hall LLC's NAGE Position: Q3 2026 in Review

Abel Hall LLC opened a new position in Niagen Bioscience (NAGE) in Q3 2026: 34,038 shares worth $99.4K. The stake represents 0.02% of the portfolio and ranks #780 among its holdings.

12 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

Abel Hall LLC held 34,038 shares of Niagen Bioscience worth $99.4K as of Q3 2026.
Niagen Bioscience was a new Abel Hall LLC position in Q3 2026.
Niagen Bioscience made up 0.02% of Abel Hall LLC's portfolio in Q3 2026, its #780 holding.
12 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.